Evidence map›Paper›PMID 33661932›Full record

ArticlePloS one2021

Quercetin/Zinc complex and stem cells: A new drug therapy to ameliorate glycometabolic control and pulmonary dysfunction in diabetes mellitus: Structural characterization and genetic studies.

Moamen S Refat, Reham Z Hamza, Abdel Majid A Adam, Hosam A Saad, Adil A Gobouri, Fatimah S Al-Harbi, Fawziah A Al-Salmi, Tariq Altalhi, Samy M El-Megharbel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antioxidants (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Chemical Characterization of Taif Rose (Antioxidants (Basel, Switzerland) · 2022
    Article
  14. Health Benefits of Quercetin in Age-Related Diseases.Molecules (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Moamen S RefatDepartment of Chemistry, College of Sciences, Taif University, Taif, Saudi Arabia.
Reham Z HamzaBiology Department, Faculty of Science, Taif University, Taif, Saudi Arabia.ORCID 0000-0001-7083-9467
Abdel Majid A AdamDepartment of Chemistry, College of Sciences, Taif University, Taif, Saudi Arabia.
Hosam A SaadDepartment of Chemistry, College of Sciences, Taif University, Taif, Saudi Arabia.
Adil A GobouriDepartment of Chemistry, College of Sciences, Taif University, Taif, Saudi Arabia.
Fatimah S Al-HarbiBiology Department, Faculty of Science, Taif University, Taif, Saudi Arabia.
Fawziah A Al-SalmiBiology Department, Faculty of Science, Taif University, Taif, Saudi Arabia.
Tariq AltalhiDepartment of Chemistry, College of Sciences, Taif University, Taif, Saudi Arabia.
Samy M El-MegharbelDepartment of Chemistry, College of Sciences, Taif University, Taif, Saudi Arabia.
Taif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal uses and applications of metals and their complexes are of increasing clinical and commercial importance. The ligation behavior of quercetin (Q), which is a flavonoid, and its Zn (II) (Q/Zn) complex were studied and characterized based on elemental analysis, molar conductance, Fourier-transform infrared (FTIR) spectra, electronic spectra, proton nuclear magnetic resonance (1H-NMR), thermogravimetric analysis, and transmission electron microscopy (TEM). FTIR spectral data revealed that Q acts as a bidentate ligand (chelating ligand) through carbonyl C(4) = O oxygen and phenolic C(3)-OH oxygen in conjugation with Zn. Electronic, FTIR, and 1H-NMR spectral data revealed that the Q/Zn complex has a distorted octahedral geometry, with the following chemical formula: [Zn(Q)(NO3)(H2O)2].5H2O. Diabetes was induced by streptozotocin (STZ) injection. A total of 70 male albino rats were divided into seven groups: control, diabetic untreated group and diabetic groups treated with either MSCs and/or Q and/or Q/Zn or their combination. Serum insulin, glucose, C-peptide, glycosylated hemoglobin, lipid profile, and enzymatic and non-enzymatic antioxidant levels were determined. Pancreatic and lung histology and TEM for pancreatic tissues in addition to gene expression of both SOD and CAT in pulmonary tissues were evaluated. MSCs in combination with Q/Zn therapy exhibited potent protective effects against STZ induced hyperglycemia and suppressed oxidative stress, genotoxicity, glycometabolic disturbances, and structural alterations. Engrafted MSCs were found inside pancreatic tissue at the end of the experiment. In conclusion, Q/Zn with MSC therapy produced a synergistic effect against oxidative stress and genotoxicity and can be considered potential ameliorative therapy against diabetes with pulmonary dysfunction, which may benefit against COVID-19.

Indexed as

Mesenchymal Stem Cell TransplantationAnimalsBlood GlucoseCells, CulturedCoordination ComplexesC-PeptideDiabetes Mellitus, ExperimentalGlycated HemoglobinHyperglycemiaHypoglycemic AgentsInsulinLungMaleOxidative StressQuercetinRatsBlood GlucoseCoordination ComplexesC-PeptideGlycated HemoglobinHypoglycemic AgentsInsulinQuercetinZinc

Identifiers

PMID33661932
PMCPMC7932096
OpenAlexW3133603689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.